Hopes of a new curative treatment for children with neuroblastoma
- OPACC
- Aug 24, 2022
- 1 min read
Children who suffer a relapse of the aggressive cancer known as neuroblastoma have small chances of survival. However, a researchers have now shown that DHODH blockers, which are well-tolerated in humans, can cure neuroblastoma in mice if administered in combination with chemotherapy. The study paves the way for clinical trials of this combination therapy.
Recent Posts
See AllDuring cancer treatment, children can face hurdles to maintaining healthy eating. Chemotherapy has many side effects, including loss of...
Quality of life improvements can be made if clinicians better understand auditory attention decay after cancer treatment in pediatric...
A team of experts, issuing a statement on behalf of the American Heart Association, have detailed cardiometabolic considerations for...
Comments